Recare is a technology company.
Recare has raised $37.9M across 2 funding rounds.
Recare has raised $37.9M in total across 2 funding rounds.
Recare is a Berlin-based health tech company that builds a web-based platform for digital discharge management, streamlining patient transfers from hospitals to post-acute care providers like rehab centers, nursing homes, and homecare services.[1][2][3] It solves the complex coordination challenges in healthcare transitions by improving communication, matching patient needs with available capacities, and optimizing care pathways, primarily serving hospitals, nursing facilities, rehabilitation centers, and care providers in Germany.[1][4] Founded in 2015 (formerly Veyo Care), Recare has raised $9.53M total, including a Series A round and recent €2.5M growth loan, with momentum shown in a +190 Mosaic Score increase and ongoing funding as of three months ago.[1][2]
The platform uses AI to enhance matching and planning, enabling faster, more efficient discharges that save time for providers and improve patient outcomes.[1][6] Recare emphasizes end-to-end encryption, ISO 27001 certification, and a B2C subscription model, positioning it as a pioneer in Germany's digital healthcare sector with 102 employees and government funding support.[4][7]
Recare was founded in 2015 in Berlin, Germany, by CEO and co-founder Maximilian Greschke, who leads the company alongside a motivated international team including key roles like Account Manager Paul Zebisch and Partner Manager Karoline Hoch.[1][2][4] Initially known as Veyo Care, it rebranded and pivoted to focus on digital discharge management, with operations ramping up notably since 2017 when it became a pioneer in web-based, encrypted hospital software.[1][4]
The idea emerged from addressing the "demanding process" of patient transfers, where hospitals struggle to coordinate with aftercare providers amid capacity constraints and communication gaps.[3][4] Early traction came through building trust in the complex German healthcare system, securing ISO certification, and attracting investors like Die Bruckenkopfe, Tech Care Paris, and Gilion (which provided a €2.5M growth loan).[1][2] Pivotal moments include recent funding rounds totaling $9.53M and official funding from the European Regional Development Fund and Investitionsbank Berlin, fueling platform innovations.[1][7]
Recare rides the wave of digital health transformation in Europe, particularly Germany's push for efficient post-acute care amid aging populations, staff shortages, and rising hospital discharge pressures.[1][4][7] Timing is ideal with EU funding like the European Regional Development Fund accelerating health tech adoption, while market forces—such as integrated care mandates and post-COVID care backlogs—favor platforms reducing readmissions and costs.[1][7]
It influences the ecosystem by pioneering encrypted, web-only solutions in a sector dominated by legacy systems, competing with mobility equipment giants like Invacare while enabling better stakeholder collaboration.[1] This positions Recare as a key enabler in value-based care trends, potentially expanding EU-wide as telehealth and AI integration grow.
Recare's momentum—with fresh funding, AI enhancements, and a certified platform—sets it up for scaling across German clinics and beyond, targeting deeper EHR integrations and international aftercare markets.[1][2][6] Trends like AI-driven personalization and regulatory tailwinds for digital health will propel growth, potentially boosting valuation as it hits Series A milestones. Its influence may evolve from niche discharge optimizer to full care pathway orchestrator, humanizing healthcare transitions much like its founders humanized the startup journey through persistent innovation.
Recare has raised $37.9M in total across 2 funding rounds.
Recare's investors include DNV, CIBC Innovation Banking, Redalpine Venture Partners.
Recare has raised $37.9M across 2 funding rounds. Most recently, it raised $35.9M Venture Round in January 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 29, 2026 | $35.9M Venture Round | DNV | CIBC Innovation Banking |
| Dec 1, 2017 | $2.0M Seed | Redalpine Venture Partners |